Ganeden Biotech, a recognized world leader in the manufacturing and marketing of probiotics, revealed that GanedenBC30 (Bacillus coagulans GBI-30, 6086) has been approved by food and drug authorities in four significant Asian markets; this means that GanedenBC30’s digestive and immune benefits are now available to Japan, India, Taiwan and the Philippines as an ingredient for food and beverage fortification.
GanedenBC30 is available as a result of the established partnerships between Maypro Industries in Japan and Connell Bros. Co. in India, Taiwan and the Philippines.
GanedenBC30 (Bacillus coagulans GBI-30, 6086) is a patented probiotic ingredient that can be found in more than 100 leading food, beverage and companion animal products throughout the world. Unlike most other probiotic strains, GanedenBC30 is a spore-former which makes it highly stable and allows it remain viable through most manufacturing processes, three years of shelf life and the low pH of stomach acid. The efficacy of GanedenBC30 is backed by 19 published studies showing digestive and immune support and GanedenBC30 has an exceptional safety record with GRAS status from the United States FDA. It can be formulated into virtually any product that is baked, boiled, frozen or squeezed, and will not change the taste or texture profile of a product.
“Japan, Taiwan, Philippines and India are significant markets within Asia, where the consumers are already familiar with the benefits of probiotics,”said Stephen Quinn, international business development and regulatory manager at Ganeden Biotech. “The regulatory approvals provide a great deal of opportunity for probiotic innovation within these thriving functional food and beverage markets; and we are thrilled to be able to introduce the unique formulating capabilities of GanedenBC30.”
On Oct. 15 to 17, Ganeden Biotech will be exhibiting in conjunction with Connell Bros. at Food Ingredients Asia in Jakarta, Indonesia. Visit booth #F21 to learn more about GanedenBC30 and the many opportunities available to help you innovate in the food and beverage industry.
Also, visit the “Food for a Quality Life” conference on Oct. 16 to hear Stephen Quinn, Ganeden Biotech's international business development and regulatory manager, speak during the “Advances in Nutrition and Health” track about Bacillus coagulans—a spore forming bacteria as novel probiotics in Asia.